Study Design: Prospective study. Purpose: To evaluate the reliability and validity of the adapted Korean version of the Quality of Life Questionnaire of the European Foundation for Osteoporosis .
Introduction
Osteoporosis is the most prevalent metabolic bone disease in older people. It has been estimated 30%-50% of women and 15%-30% of men will suffer an osteoporotic fracture [1] . Vertebral fracture is one of the most common osteoporotic fractures; it is a major public health problem that affects millions of people worldwide [2, 3] . In the Korean population, the standardized prevalence for vertebral fractures using the age distribution has been reported to be 12.6% in women and 8.8% in men [4] .
Vertebral fractures are associated with significant morbidity in terms of physical and psychological functioning and reduced health-related quality of life (HRQoL) [5] [6] [7] [8] [9] [10] . Furthermore, the sum of physical, social and mental functioning has played an important role in clinical studies, particularly as an outcome measure in clinical trials [11, 12] .
Several generic instruments have been developed for measuring QoL, such as short form-36, the Sickness Impact Profile and the Nottingham Health Profile [13] [14] [15] . These generic instruments give a general estimate of health and are not specific for any disease. Thus, several disease-specific questionnaires with good validity and reliability have been designed to assess QoL in patients with osteoporosis. These include the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41) [7] , the Osteoporosis Quality of Life Questionnaire (OQLQ) [16] , mini-OQLQ, ECOS-16 [17] , the Osteoporosis Assessment Questionnaire (OPAQ), and the Osteoporosis Functional Disability Questionnaire (OFDQ).
ECOS-16 was developed to evaluate quality of life in postmenopausal osteoporotic patients based on the osteoporosis specific quality of life instruments QUALEFFO [7] and OQLQ [16] . ECOS-16 contains 12 items from QUALEFFO and four items from OQLQ. The 16 items in ECOS-16 are divided in the four dimensions of physical functioning, pain, fear of illness and psychosocial function. Five response options are offered per item with scores varying between 1 and 5 points, where 5 represents the worst QoL score [17] .
This questionnaire has been translated into different languages and has been judged valid. These kinds of questionnaires must be translated into the respective local languages and must also be culturally adapted. The objectives of this study were to translate a culturally adapted version of the ECOS-16 questionnaire into the Korean language and to validate this version in Korean patients.
Materials and Methods
This study was approved by the ethics committee of our institute.
The translation procedure in this study followed the guidelines for the cross-cultural adaptation of self-report measures [18] . The translation procedure was conducted in three stages: forward translation, back translation, and expert committee discussion. In addition, a pilot study was performed to determine whether the prefinal version could be understood correctly by Korean osteoporosis or osteopenia patients. The final version resulting from expert committee discussion was tested for validity and reliability using the Korean version of the short form-36 (SF-36) [19] .
The forward translation was completed by two native Korean translators. The first translator was an orthopaedic surgeon and the other was a professional translator with no medical background who was not initially informed of the purpose of the translation. The two translators' versions and the original version were compared and discussed by the two translators and another orthopaedic surgeon, until agreement was reached.
The back translation was completed independently by two bilingual translators whose native language was English. Both of these translators lacked a medical background and were not informed or aware of the prior translation procedures.
All versions of the translation as well as the original were discussed by the four translators and an expert committee comprised of three bilingual experts, two orthopaedic surgeons, and a Korean translation expert. This committee discussed the translation procedure and results until consensus was reached regarding discrepancies. The result was the prefinal version of the ECOS-16 questionnaire.
This prefinal version was administered to 40 Koreanspeaking female osteoporosis or osteopenia patients, who were questioned regarding their understanding of the questionnaire items and their responses. The mean age was 61.3 years (range, 48-76 years). The interviewer was asked to document any problems that occurred during administration of the questionnaire. In addition, at the end of all interviews the patients were asked to provide comments about the questionnaire and to identify any words that were difficult to understand. All 40 patients correctly understood the questionnaire. The final form of the Korean version of the ECOS-16 questionnaire was determined by the expert committee, with the participation of all translators and a consensus was achieved (Appendix 1).
A total of 158 consecutive patients with osteoporosis were included in this study. Eighty one (51.3%) had at least one morphometrically defined vertebral fracture and, as the control, 77 (48.7%) were osteoporosis or osteopenia patients without a fracture were included. The World Health Organization classification for osteoporosis was used throughout the study. Patients with any notable physical disorder, metabolic bone disease, or malignancy were excluded. Osteoporotic patients with a clinical (symptomatic) vertebral fracture were also excluded. Control subjects were required to have no apparent kyphosis and no morphometric vertebral fracture. Lumbar spine magnetic resonance imaging (MRI) was performed with all subjects to find a symptomatic vertebral fracture.
Lumbar spinal bone mineral density (LSBMD) and femoral neck BMD (FNBMD) of the non-dominant proximal femur were measured by dual-energy X-ray absorptiometry (DEXA) using a XR-36 apparatus (Norland Co., Fort Atkinson, WI, USA). LSBMD was measured in L1 to L4 in the anterior-posterior view. This study defined osteoporosis and osteopenia as BMD lowest T-score at any site ≤-2.5 and -1.50 to -2.49, respectively, at the lumbar spine or hip.
The Korean version of the visual analog scale (VAS) measure of pain, ECOS-16, and SF-36 were mailed to 158 consecutive patients (127 females, 31 males) with osteoporosis or osteopenia. First mailing contained a consent form; description of the study; Korean versions of VAS measure for pain, ECOS-16, and SF-36; and an addressed and stamped return envelope. One hundred and twenty one patients (97 females, 24 males) responded to the first set of questionnaires. One hundred two (80 females, 22 males) of the first-time respondents returned the second survey. The average age of the 102 patients was 63.5 years (range, 51-79 years) at the time of survey, and the average time between first and second mailings was 2 weeks.
Test-retest reliability was measured by comparing responses to first and second ECOS-16 assessments. Reliability was assessed using kappa statistics of agreement for each items of ECOS-16 and by calculating the intraclass correlation coefficient (ICC2, ICC1). Cronbach's α was used to evaluate internal consistency. Factor analysis used was to determine the dimensionality of the ECOS-16 items. An item loading on each factor ≥0.4 was considered satisfactory. Individual domain scores were calculated by summing item scores, which were then linearly transformed to a 0-100 scale, where 100 represented poor health. Floor and ceiling effects were assessed by calculating the percentages of subjects with lowest or highest possible domain scores, respectively. Concurrent and construct validity were evaluated by comparing the responses of ECOS-16 with the results of VAS and responses of SF-36 using Pearson's correlation coefficient. The distributions of floor and ceiling effects of the Korean 
Results
One hundred fifty eight native Korean-speaking patients with osteoporosis or osteopenia were enrolled. One hundred and two patients completed the second assessment. Table 1 summarizes the demographic characteristics of the study population. Mean scores on ECOS-16 and SF-36 for fracture cases and controls are shown in Table 2 . Subjects with a vertebral fracture showed significant impairment of HRQoL on the ECOS-16 compared with controls. Similar results Table  6 . When we investigated the relationship between Korean ECOS-16 and SF-36 scores, we obtained r of -0.7643. Convergent validity for the Korean ECOS-16 was demonstrated by moderate to high correlations (r=0.5-0.8). Strong correlations were observed between ECOS-16 pain scores and SF-36 bodily pain scores (r=-0.665), ECOS-16 physical function scores and SF-36 physical functioning scores (r=-0.713), and ECOS-16 mental function score and SF-36 mental health score (r=-0.536). Correlation coefficients between the domain scores of Korean ECOS-16 and other domain scores of SF-36 were relatively weak (r<0.5), indicating adequate divergent validity. No ceiling or floor effects were observed for the Korean ECOS-16. The worst ECOS-16 score was 63.8 in two patients and the best was 14.7 in one patient.
Discussion
The objective of this study was to produce a Korean version of ECOS-16 by translation and adaption. The Korean version of ECOS-16 was clearly understood by and easily administered to patients. The results indicate that the Korean version of the ECOS-16 is a reliable and valid instrument for measuring outcomes in Korean patients with osteoporosis or osteopenia, with reliability levels similar to those of the original [17] , Turkish [20] , and Italian [21] versions.
Regarding factor analysis, although the original and Italian versions have a four-factor structure [17, 21] , this study revealed three-factor solutions for the ECOS-16. The Turkish study did not perform factor analysis. [17, 20, 21] . These results show that this translated version is reliable and has low standard errors of measurement.
The reliabilities of functional status questionnaires can be measured using an interval of 1 to 2 weeks between assessments, because during this time clinical status is unlikely to change appreciably in patients with chronic pain in the absence of specific intervention. In the present study, we mailed the Korean version of VAS for pain, ECOS-16, and SF-36 to 158 osteoporosis or osteopenia patients. The reproducibilities of its 16 items were satisfactory with kappa values of agreement exceeding 0.6. Moreover, agreement between items was good; the ICC of 0.897 indicates the Korean version of ECOS-16 has good reliability.
Our analysis of concurrent validity showed a positive correlation between the Korean version of ECOS-16 and VAS. Furthermore, regarding construct validity, we expected ECOS-16 would show correlations with healthrelated QoL scales. Therefore, we analyzed construct validity by comparing ECOS-16 total scores to SF-36 total score; a high correlation was found (p<0.001). We also compared the total scores of ECOS-16 and three subscales to each domain of SF-36. According to the meanings of the subscales, the correlations between the pain domain of ECOS-16 and the bodily pain domain of SF-36 (r=-0.665), between the physical function domain of ECOS-16 and the physical functioning domain of SF-36 (r=-0.713), and between mental function domain of ECOS-16 and mental health domain of SF-36 (r=-0.536) were stronger than other functional domains of the SF-36.
Before interpreting the results of the current study, several limitations must be considered. First, the number of subjects recruited was relatively small. Because symptoms of patients with a clinical (symptomatic) vertebral fracture might be easily changed by treatment, which could reduce the reproducibility of questionnaire, this study did not enroll these patients. Second, our subjects were osteoporosis or osteopenia patients, recruited at one spine center, and were a convenient sample, not randomly selected. Accordingly, generalizability of our quality of life scores is limited. Third, time between test and retest was relatively short which might have positively biased our reliability results.
Conclusions
The Korean version of ECOS-16 is the first conditionspecific outcome instrument for patients with osteoporosis or osteopenia to be validated in a Korean population. The development and validation of multiple-language versions of existing validated questionnaires plays a key role in standardizing outcome measurements and increasing the statistical powers of clinical studies. ECOS-16 was successfully translated into Korean and the psychometric properties of the original version were not lost. Accordingly, the Korean version of the ECOS-16 appears to be a reliable and valid outcome measure of functional status in Korean patients with osteoporosis or osteopenia. We recommend that this Korean version of the ECOS-16 be utilized for future clinical studies conducted in Korea.
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